Implementation of New Exercise Protocols in Cardiac Rehabilitation.
REVACARD
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
- Primary Objective: To evaluate the effects of complementary exercise protocols in cardiac rehabilitation (CR), such as inspiratory muscle training (IMT), by assessing inspiratory muscle strength.
- Secondary Objectives: To assess functional capacity, quality of life (QoL), and pulmonary function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
ExpectedSeptember 23, 2025
September 1, 2025
Same day
March 21, 2025
September 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximal inspiratory pressure
1 year
Study Arms (2)
control group
NO INTERVENTIONintervention group
EXPERIMENTALInterventions
inspiratory muscle training for intervention group
Eligibility Criteria
You may qualify if:
- \- Patient meeting the conditions of the permanent life support agreement following hospitalization for a cardiac condition such as: acute myocardial infarction; coronary surgery; therapeutic percutaneous endovascular intervention on the coronary arteries, under medical imaging guidance; therapeutic percutaneous endovascular intervention on the heart, under medical imaging guidance; surgery for congenital or acquired heart malformation; surgery for valvular lesion; heart transplantation; resistant angina (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care); cardiomyopathy with left ventricular dysfunction (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care).
- Patient aged between 18 and 80 years.
- Patient capable of giving informed consent.
- Patient registered for permanent life support at the CuSL.
- Patient capable of understanding instructions in French. - Patient with prior medical consent and clinically stable.
You may not qualify if:
- \- Minor (\<18 years old).
- Pregnant woman.
- Patient unable to provide informed consent.
- Patient with cognitive, neurological, or orthopedic limitations.
- Patient with mobility or musculoskeletal difficulties incompatible with physical activity.
- Clinical instability.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 21, 2025
First Posted
September 8, 2025
Study Start
December 1, 2025
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 31, 2029
Last Updated
September 23, 2025
Record last verified: 2025-09